In a murine ApoE-/- model for atherosclerosis, Yan, Wang [59] determined metformin treatment altered microbiome diversity in a treatment-dependent manner; specifically, Romboutsia decreased in abundance due to metformin treatment and was positively associated with inflammatory immune markers and negatively correlated with various short chain fatty acids. The gene discussed is APOE; the disease is atherosclerosis.